BUY Pine Labs Limited — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred 1 year)4 Nov 2026via Economic Times New Stock Recos
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
5 other SEBI-registered advisors have active long-term BUY calls on this stock, with 2 issued in the last 14 days
Advisor consensus · same horizon·30 Oct · 1w ago
Pine Labs shares jump 7% as Q2 net profit soars 543% YoY to Rs 39 crore
NewsEt-Markets·29 Oct · 1w ago
Pine Labs Q2 Results: Revenue growth hits five-quarter high at 24%; EBITDA rises 67%
NewsCnbc-Tv18·29 Oct · 1w ago
Pine Labs Q2 Results: Profit Rockets Multifold, Revenue Jumps 24%
NewsNdtv-Profit·29 Oct · 1w ago
Pine Labs Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
NSE · Outcome of Board Meeting·29 Oct · 1w ago
Here's why Paytm, Pine Labs, MobiKwik shares fell up to 7% and then recovered
NewsCnbc-Tv18·13 Oct · 4w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Pine Labs
- BUY — Emkay Global30 Oct 2026 · ~1 year · target ₹220 · Active
- BUY — Citigroup30 Oct 2026 · ~1 year · target ₹220 · Active
- BUY — Mehul Kothari, Anand Rathi28 Oct 2026 · ~2 weeks · target ₹180 · SL hit
- BUY — Jigar S Patel, Anand Rathi28 Sept 2026 · ~2 weeks · target ₹200 · Expired
- BUY — Mahesh Ojha, Kantilal Chhaganlal Securities23 Sept 2026 · ~1 year · target ₹260 · Active
More from ICICI Securities
- BUY ICICI Bank5 Nov 2026 · ~1 year · target ₹1,800 · Active
- BUY Stylam Industries5 Nov 2026 · ~1 year · target ₹3,750 · Active
- BUY Emcure Pharmaceuticals5 Nov 2026 · ~1 year · target ₹2,560 · Active
- BUY Saregama India5 Nov 2026 · ~1 year · target ₹740 · Active
- BUY Procter & Gamble Health4 Nov 2026 · ~1 year · target ₹6,680 · Active

